A single dose of human papillomavirus (HPV) vaccine could be effective for preventing cervical cancer, raising hopes of fighting the disease in Sub-Saharan Africa, a conference has heard.
Only 15% of girls globally are vaccinated against human papillomavirus (HPV), but single-dose vaccination could pave the way for much better infection control, new research suggests.